|
EXHIBIT 10.1
Securities Purchase Agreement
The undersigned investor (the " Investor ") hereby
confirms Investor’s agreement with Arcadia Resources, Inc.
("Arcadia" or the "Company") as follows:
1. This Securities Purchase Agreement is made as of the
date set forth below between the Company and the Investor.
2. The Company has authorized the sale and issuance of
4,999,999 shares (the " Shares ") of the common stock of the
Company, $0.001 par value per share (the " Common Stock "),
to the Investor in a private placement (the " Offering
").
3. The Company and the Investor agree that the Investor
will purchase from the Company and the Company will issue and sell
to the Investor 4,999,999 Shares at a purchase price of $2.00 per
Share, for an aggregate purchase price of $9,999,998.00 (the "
Purchase Price "), subject to the Terms and Conditions for
Purchase of Shares attached hereto as Annex I and incorporated
herein by reference as if fully set forth herein. Unless otherwise
requested by the Investor in Exhibit "A", certificates representing
the Shares purchased by the Investor will be registered in the
Investor’s name and address as set forth below.
4. The Investor represents that, except as set forth
below, (a) it has had no position, office or other material
relationship within the past three (3) years with the Company
or its affiliates, (b) neither it, nor any group of which it
is a member or to which it is related, beneficially owns (including
the right to acquire or vote) any securities of the Company, (c)
neither it, nor any group of which it is a member or to which it is
related, acquired, directly or indirectly, any securities of the
Company in a certain private placement transaction that closed on
November 30, 2006, and (d) it has no direct or indirect
affiliation or association with any National Association of
Securities Dealers, Inc. (" NASD ") member. Exceptions:
(If no exceptions, write "none."
If left blank, response will be deemed to be "none.")
Please confirm that the foregoing correctly sets forth the
agreement between us by signing in the space provided below for
that purpose.
|
|
|
|
|
|
|
|
|
|
|
Dated as of: December 28, 2006
|
|
|
|
|
|
|
|
|
|
|
|
Capital Research and Management
Company
|
|
|
|
on behalf of SMALLCAP World Fund, Inc.
and
|
|
|
|
American Funds Insurance Series, Global
Small
|
|
|
|
Capitalization Fund
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
By:
|
/s/ Catherine M. Ward
|
|
|
|
|
Name:
|
Catherine M. Ward
|
|
|
|
|
Title:
|
Sr. Vice President
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Address:
|
|
333 S. Hope St.
|
|
|
|
|
|
|
|
Los Angeles, CA
|
|
|
|
|
|
|
|
90071
|
|
|
AGREED AND ACCEPTED :
Arcadia Resources, Inc.
|
|
|
|
|
|
|
By:
|
|
/s/ John E. Elliott, II
|
|
|
|
|
|
|
|
|
|
|
|
Name: John E. Elliott, II
|
|
|
|
|
|
Title: Chairman and CEO
|
|
|
[SECURITIES PURCHASE AGREEMENT
SIGNATURE PAGE]
2
Annex I
Terms and Conditions for Purchase of
Shares
1. Agreement to Sell and
Purchase the Shares; Subscription Date.
1.1 Purchase and Sale . At the Closing (as defined in
Section 2), the Company will sell to the Investor, and the
Investor will purchase from the Company, upon the terms and subject
to the conditions set forth herein, and at the Purchase Price, the
number of Shares described in paragraph 3 of the Securities
Purchase Agreement attached hereto (collectively with this Annex I
and the other exhibits attached hereto, this " Agreement ").
The Registration Rights Agreement and the Securities Purchase
Agreement executed by the Investor are sometimes collectively
referred to herein as the " Agreements ." The Investor must
execute and deliver the Securities Purchase Agreement and the
Registration Rights Agreement and must complete the Stock
Certificate Questionnaire (in the form attached as Exhibit "A"
hereto) and the Investor Questionnaire (in the form attached as
Exhibit "B" hereto) in order to purchase Shares.
1.2 Placement Agent Fee . The Investor acknowledges that the
Company intends to pay to The Shemano Group, Inc. (in its capacity
as placement agent for the Shares, the " Placement Agent ")
a fee in respect of the sale of Shares to the Investor from the
proceeds of the Offering.
2. Delivery of the Shares
at Closing. The completion of the purchase and sale of the
Shares (the " Closing ") shall occur on a date specified by
the Company and the Placement Agent that is anticipated to be
December 28, 2006 (the " Closing Date "), but which
date shall not be later than December 29, 2006 (the "
Outside Date "), and of which the Investor will be notified
in advance by the Placement Agent. At the Closing or upon AMEX
listing approval of the Shares, whichever is later, the Company
shall deliver to the Investor one or more stock certificates
representing the number of Shares set forth in paragraph 3 of the
Stock Purchase Agreement, each such certificate to be registered in
the name of the Investor or, if so indicated on the Stock
Certificate Questionnaire, in the name of a nominee designated by
the Investor. In exchange for the delivery of the subscription
agreements, the Investor shall deliver at Closing the Purchase
Price directly to the Company by wire transfer of immediately
available funds pursuant to written instructions. On the Closing
Date, the Company shall cause counsel to the Company to deliver to
the Investors a legal opinion, dated the Closing Date, in the form
attached hereto as Exhibit "C" (the " Legal Opinion ").
The Company’s obligation to
issue and sell the Shares to the Investor shall be subject to the
following conditions, any one or more of which may be waived by the
Company: (a) prior receipt by the Company of an executed copy
of this Securities Purchase Agreement; (b) the accuracy of the
representations and warranties made by the Investor in this
Agreement and the fulfillment of the obligations of the Investor to
be fulfilled by it under this Agreement on or prior to the Closing;
(c) the Company is satisfied that the issuance of the
Securities will not be in violation of applicable AMEX listing
qualification rules; and (d) the absence of any order, writ,
injunction, judgment or decree that questions the validity of the
Agreements or the right of the Company or the Investor to enter
into such Agreements or to consummate the transactions contemplated
hereby and thereby.
The Investor’s obligation to
purchase the Shares shall be subject to the following conditions,
any one or more of which may be waived by the Investor:
(a) the delivery of the Legal Opinion to the Investor by
counsel to the Company; (b) the accuracy of the
representations and warranties made by the Company in this
Agreement on the Closing Date; (c) the execution and delivery
by the Company of the Registration Rights Agreement; and
(d) the absence of any order, writ, injunction, judgment or
decree that questions the validity of the Agreements or the right
of the Company or the Investor to enter into such Agreements or to
consummate the transactions contemplated hereby and thereby.
1
In the event that the Closing does
not occur on or before the Outside Date as a result of the
Company’s failure to satisfy any of the conditions set forth
above (and such condition has not been waived by the Investor), the
Company shall return any and all funds paid hereunder to the
Investor no later than one Business Day following the Outside Date
and the Investors shall have no further obligations hereunder. For
purposes of this Agreement, " Business Day " shall mean any
day other than a Saturday, Sunday or other day on which the New
York Stock Exchange is permitted or required by law to close.
3. Representations,
Warranties and Covenants of the Company. Except as otherwise
described in the Company’s Annual Report on Form 10-K for the
year ended March 31, 2006 (and any amendments thereto filed at
least two (2) Business Days prior to the Closing Date), the
Company’s S-1 Registration Statement effective July 18,
2006, the Company’s most recent Quarterly Report on Form 10-Q
for the quarter ended September 30, 2006, the Company’s
Proxy Statement for its 2006 Annual Meeting of Shareholders, and
any of the Company’s Current Reports on Form 8-K filed since
March 31, 2006 (and any amendments thereto filed at least two
(2) Business Days prior to the Closing Date) (all
collectively, the " SEC Reports "), the Company hereby
represents and warrants to, and covenants with, the Investor as of
the date hereof and the Closing Date, as follows:
3.1 Organization. The Company is duly incorporated and
validly existing in good standing under the laws of the State of
Nevada. The Company has full power and authority to own, operate
and occupy its properties and to conduct its business as presently
conducted and is registered or qualified to do business and in good
standing in each jurisdiction in which it owns property or
transacts business and where the failure to be so qualified would
have a material adverse effect upon the Company and its
subsidiaries as a whole or the business, financial condition,
properties, operations or assets of the Company and its
subsidiaries as a whole or the Company’s ability to perform
its obligations under the Agreements in all material respects ("
Material Adverse Effect "), and no proceeding has been
instituted in any such jurisdiction revoking, limiting or
curtailing, or seeking to revoke, limit or curtail, such power and
authority or qualification.
3.2 Due Authorization. The Agreements have been validly
executed and delivered by the Company and constitute legal, valid
and binding agreements of the Company enforceable against the
Company in accordance with their terms, except to the extent
(i) rights to indemnity and contribution may be limited by
state or federal securities laws or the public policy underlying
such laws, (ii) such enforceability may be limited by
applicable bankruptcy, insolvency, reorganization, moratorium or
similar laws affecting creditors’ and contracting
parties’ rights generally and (iii) such enforceability
may be subject to general principles of equity (regardless of
whether such enforceability is considered in a proceeding in equity
or at law).
3.3 No Conflict or Default. The execution and delivery of
the Agreements, the issuance and sale of the Shares to be sold by
the Company under the Agreements, the fulfillment of the terms of
the Agreements and the consummation of the transactions
contemplated thereby will not: (A) result in a conflict with
or constitute a material violation of, or material default (with
the passage of time or otherwise) under, (i) any bond,
debenture, note, loan agreement or other evidence of indebtedness,
or any material lease, or contract to which the Company is a party
or by which the Company or their respective properties are bound,
(ii) the Certificate of Incorporation, by-laws or other
organizational documents of the Company, as amended, or
(iii) any law, administrative regulation, or existing order of
any court or governmental agency, or other authority binding upon
the Company or the Company’s respective properties; or,
(B) result in the creation or imposition of any lien,
encumbrance, claim, or
2
security interest upon any of the material assets of the Company
or an acceleration of indebtedness pursuant to any obligation,
agreement or condition contained in any material bond, debenture,
note or any other evidence of indebtedness or any material
indenture, mortgage, deed of trust or any other agreement or
instrument to which the Company is a party or by which it is bound
or to which any of the property or assets of the Company is
subject, that would have a Material Adverse Effect. Except for AMEX
listing approval of the Shares, no consent, approval, authorization
or other order of, or registration, qualification or filing with,
any regulatory body, administrative agency, or other governmental
body is required for the execution and delivery of the Agreements
by the Company and the valid issuance or sale of the Shares by the
Company pursuant to the Agreements, other than such as have been
made or obtained, and except for any filings required to be made
under federal or state securities laws.
3.4 Capitalization. The
outstanding capital stock of the Company is as described in the
Company’s Quarterly Report on Form 10-Q for the three month
period ending September 30, 2006. Except as described in the
SEC Reports, since September 30, 2006, the Company has not
issued any capital stock, other than pursuant to the purchase of
shares under the Company’s employee stock option plan and the
exercise of outstanding warrants or stock options. The Shares to be
sold pursuant to the Agreements have been duly authorized, and when
issued and paid for in accordance with the terms of the Agreements,
will be duly and validly issued, fully paid and nonassessable,
subject to no lien, claim or encumbrance (except for any such lien,
claim or encumbrance created, directly or indirectly, by the
Investor). The outstanding shares of capital stock of the Company
have been duly and validly issued and are fully paid and
nonassessable, have been issued in compliance with the registration
requirements of federal and state securities laws, and were not
issued in violation of any preemptive rights or similar rights to
subscribe for or purchase securities. The Company owns one hundred
percent of all of the outstanding capital stock of each of its
subsidiaries, free and clear of all liens, claims and encumbrances,
except for Care Clinic, Inc. as to which the Company owns 85% of
the outstanding capital stock. There are not (i) any
outstanding preemptive rights except as described in the SEC
Reports, or (ii) any rights, warrants or options to acquire,
or instruments convertible into or exchangeable for, any unissued
shares of capital stock or other equity interest in the Company not
disclosed in the SEC Reports, or (iii) any contract or agreement to
which the Company is a party that would provide for the issuance or
sale of any capital stock of the Company, any such convertible or
exchangeable securities or any such rights, warrants or options not
disclosed in the SEC Reports. There are no shareholders agreements,
voting agreements or other similar agreements with respect to the
Common Stock to which the Company is a party, other than as
described in SEC Reports.
3.5 Legal Proceedings.
There is no material legal or governmental proceeding pending, or
to the actual knowledge of the Company, threatened, to which the
Company is a party or of which the business or property of the
Company is subject that is required to be disclosed and that is not
so disclosed in the SEC Reports. Other than the information
disclosed in the SEC Reports, the Company is not subject to any
injunction, judgment, decree or order of any court, regulatory
body, administrative agency or other government body. !
3.6 No Violations. The
Company is not in violation of its Certificate of Incorporation,
bylaws or other organizational documents, as amended, that is
reasonably likely to have a Material Adverse Effect. The Company is
not in violation of any law, administrative regulation, ordinance
or order of any court or governmental agency, arbitration panel or
authority applicable to the Company, which violation, individually
or in the aggregate, is reasonably likely to have a Material
Adverse Effect. The Company is not in default (and there exists no
condition which, with the passage of time or otherwise, would
constitute a default) in the performance of any bond, debenture,
note or any other evidence of indebtedness or any indenture,
mortgage, deed of trust or any other material agreement or
instrument to which the Company is a party or by which the Company
is bound, which such default is reasonably likely to have a
Material Adverse Effect upon the Company.
3
3.7 Governmental Permits,
Etc. The Company has all necessary franchises, licenses,
certificates and other authorizations from any foreign, federal,
state or local government or governmental agency, department or
body that are currently necessary for the operation of the business
of the Company as currently conducted, except where the failure to
currently possess such franchises, licenses, certificates and other
authorizations is not reasonably likely to have a Material Adverse
Effect.
3.8 Intellectual
Property.
(a) Except for matters which are not reasonably likely to
have a Material Adverse Effect, (i) each of the Company has
ownership of, or a license or other legal right to use, all
patents, copyrights, trade secrets, trademarks, customer lists,
designs, manufacturing or other processes, computer software,
systems, data compilation, research results or other proprietary
rights used in the business of the Company (collectively, "
Intellectual Property ") and (ii) all of the
Intellectual Property owned by the Company consisting of patents,
registered trademarks and registered copyrights have been duly
registered in, filed in or issued by the United States Patent and
Trademark Office, the United States Register of Copyrights or the
corresponding offices of other jurisdictions and have been
maintained and renewed in accordance with all applicable provisions
of law and administrative regulations in the United States and/or
such other jurisdictions.
(b) Except for matters which are not reasonably likely to
have a Material Adverse Effect, all material licenses or other
material agreements under which (i) the Company employs rights
in Intellectual Property, or (ii) the Company has granted
rights to others in Intellectual Property owned or licensed by the
Company are in full force and effect, and there is no default by
the Company with respect thereto.
(c) The Company believes that it has taken all steps
reasonably required in accordance with sound business practice and
business judgment to establish and preserve the ownership of the
Company’s material Intellectual Property.
(d) Except for matters which are not reasonably likely to
have a Material Adverse Effect, to the actual knowledge of the
Company, (i) the present business, activities and products of
the Company do not infringe any intellectual property of any other
person; (ii) neither the Company is making unauthorized use of
any confidential information or trade secrets of any person; and
(iii) the activities of any of the employees of the Company,
acting on behalf of the Company, do not materially violate any
agreements or arrangements related to confidential information or
trade secrets of third parties.
(e) Except for matters which are not reasonably likely to
have a Material Adverse Effect, and except as disclosed in the SEC
Reports, no proceedings are pending, or to the knowledge of the
Company, threatened, which challenge the rights of the Company to
the use the Company’s Intellectual Property.
3.9 Financial Statements.
The financial statements of the Company and the related notes
contained in the SEC Reports present fairly in all material
respects the financial position of the Company as of the dates
therein indicated, and the results of its operations, cash flows
and the changes in shareholders’ equity for the periods
therein specified, subject, in the case of unaudited financial
statements for interim periods, to normal year-end audit
adjustments. Such financial statements (including the related
notes) have been prepared in accordance with generally accepted
accounting principles applied on a consistent basis at the times
and throughout the periods therein specified, except that unaudited
financial statements may not contain all footnotes required by
generally accepted accounting principles.
4
3.10 No Material Adverse
Change. Except as disclosed in the SEC Reports or in any press
releases issued by the Company at least two (2) Business Days
prior to the Closing Date, there has not been (i) an event,
circumstance or change that has had or is reasonably likely to have
a Material Adverse Effect upon the Company, (ii) any
obligation incurred by the Company that is material to the Company,
(iii) any dividend or distribution of any kind declared, paid
or made on the capital stock of the Company, or (iv) any loss
or damage (whether or not insured) to the physical property of the
Company which has had a Material Adverse Effect.
3.11 AMEX Compliance. The
Company’s Common Stock is registered pursuant to Section
12(b) of the Securities Exchange Act of 1934, as amended (the "
Exchange Act "), and is listed on the American Stock
Exchange (" AMEX "), and the Company has taken no action
intended to, or which to its actual knowledge could have the effect
of, terminating the registration of the Common Stock under the
Exchange Act or delisting the Common Stock from AMEX.
3.12 Reporting Status. The
Company has timely made all filings required under the Exchange Act
during the twelve (12) months preceding the date of this
Agreement, and all of those documents complied in all material
respects with the SEC’s requirements as of their respective
filing dates, and the information contained therein as of the
respective dates thereof did not contain an untrue statement of a
material fact or omit to state a material fact required to be
stated therein or necessary to make the statements therein in light
of the circumstances under which they were made not misleading. The
Company is currently eligible to register the resale of Common
Stock by the Investors pursuant to a registration statement on Form
S-3 under the Securities Act or on such other form as may be
available to the Company (the " Registration Statement
").
3.13 No Manipulation;
Disclosure of Information. The Company has not taken and will
not take any action designed to or that might reasonably be
expected to cause or result in an unlawful manipulation of the
price of the Common Stock to facilitate the sale or resale of the
Shares. The Company has not disclosed any material non-public
information to the Investors.
3.14 Accountants. BDO
Seidman, LLP, who expressed their opinion with respect to the
consolidated financial statements in the Company
|